Rochester Medical Corporation  

(Public, NASDAQ:ROCM)   Watch this stock  
Find more results for ROCM
14.68
-0.03 (-0.20%)
May 21 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 14.54 - 14.84
52 week 9.11 - 15.34
Open 14.67
Vol / Avg. 25,932.00/54,977.00
Mkt cap 179.13M
P/E 49.42
Div/yield     -
EPS 0.30
Shares 12.20M
Beta 0.87
Inst. own 43%
Jul 22, 2013
Q3 2013 Rochester Medical Corporation Earnings Release Add to calendar
Apr 25, 2013
Q2 2013 Rochester Medical Corporation Earnings Conference Call - Webcast
Apr 22, 2013
Q2 2013 Rochester Medical Corporation Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 7.21% 3.32%
Operating margin 10.66% 5.21%
EBITD margin - 9.41%
Return on average assets 6.23% 2.46%
Return on average equity 6.82% 3.05%
Employees 344 -
Carbon Disclosure Rating - -

Address

One Rochester Medical Drive
STEWARTVILLE, MN 55976-1647
United States - Map
+1-507-5339600 (Phone)
+1-507-5339725 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Rochester Medical Corporation develops, manufactures and markets a range of polyvinyl chloride (PVC)-free and latex-free urinary continence and urine drainage care products for the extended care and acute care markets. The Company�s extended care products include a range of male external catheters (MECs) for managing male urinary incontinence and a range of intermittent catheters for managing both male and female urinary retention. It also sells a range of latex male external catheters in the United Kingdom. Its Magic3 is a range of silicone intermittent catheters. Its extended care products also include the FemSoft Insert, a soft, liquid-filled, conformable urethral insert for managing female stress urinary incontinence in adult females. Its acute care products include a range of standard Foley catheters, Strata brand of Foley catheters, and Strata-NF Catheter, an antibacterial Foley catheter that reduces the incidence of hospital acquired urinary tract infection (UTI).

Officers and directors

Anthony J. Conway Chairman of the Board, President, Chief Executive Officer
Age: 68
Bio & Compensation  - Reuters
David A. Jonas Chief Financial Officer, Treasurer, Secretary, Director
Age: 48
Bio & Compensation  - Reuters
James M. Carper Vice President - U.S. Sales and Marketing
Age: 61
Bio & Compensation  - Reuters
Robert M. Anglin Vice President - Quality & Regulatory
Age: 45
Bio & Compensation  - Reuters
Philip J. Conway Vice President - Production Technologies
Age: 55
Bio & Compensation  - Reuters
Sarah L. Grinde Vice President - Development & Research
Age: 39
Bio & Compensation  - Reuters
Martyn R. Sholtis Corporate Vice President
Age: 53
Bio & Compensation  - Reuters
Darnell L. Boehm Independent Director
Age: 64
Bio & Compensation  - Reuters
Peter H. Shepard Independent Director
Age: 67
Bio & Compensation  - Reuters